The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors
Patrick Vermersch(Université de Lille), Celia Oreja‐Guevara, Maura Pugliatti(University of Sassari), Veronica Popescu(Hasselt University), Laura Airas(Turku University Hospital), Florian Deisenhammer(University of Vienna), Hans‐Peter Hartung(The University of Sydney), Nikolaos Grigoriadis(Aristotle University of Thessaloniki), Carlo Pozzilli(Ophthalmology Clinic), Thomas Berger(Medical University of Vienna), Melinda Magyari(University of Copenhagen), Bart Van Wijmeersch(Hasselt University), Magd Zakaria(Ain Shams University)
Cited by 17
Related Papers
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k